To compare safety and efficacy of pantoprazole with pantoprazole plus amitriptyline in patients of functional dyspepsia.
Not Applicable
- Conditions
- Health Condition 1: K30- Functional dyspepsiaHealth Condition 2: K297- Gastritis, unspecifiedHealth Condition 3: K219- Gastro-esophageal reflux disease without esophagitis
- Registration Number
- CTRI/2023/07/055175
- Lead Sponsor
- Dr Rajendra Prasad Government Medical College Tanda at kangra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Functional dyspepsia patients ( no evidence of any structural disease likely to explain the symptoms including upper gastrointestinal endoscopy)
Exclusion Criteria
1) Patients Not willing to give written informed consent .
2) Pregnant females.
3) Lactating females.
4) Active alcohol users.
5) Patients allergic or with known contraindications to any of study drugs.
6) Patients who are known case of cirrhosis ,chronic kidney disease, chronic heart disease,glaucoma , history of seizure , retention of urine .
7) use of similar drugs during last 2 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Glasgow dyspepsia severity score,short form Leeds dyspepsia questionnaire and visual analogue scale in functional dyspepsia patientsTimepoint: After 4 weeks of enrollment
- Secondary Outcome Measures
Name Time Method To evaluate the safety of two drugsTimepoint: From the initiation of treatment to 4 weeks after initiation of treatment